Anja Rippert
Overview
Explore the profile of Anja Rippert including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
298
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Schieck E, Poole E, Rippert A, Peshu J, Sasi P, Borrmann S, et al.
Malar J
. 2017 Nov;
16(1):450.
PMID: 29115961
Background: During intra-erythrocytic replication Plasmodium falciparum escapes the human host immune system by switching expression of variant surface antigens (VSA). Piecemeal acquisition of variant specific antibody responses to these antigens...
2.
Stanifer M, Kischnick C, Rippert A, Albrecht D, Boulant S
Sci Rep
. 2017 Sep;
7(1):10873.
PMID: 28883463
Upon viral infection, an arms-race between the cellular intrinsic innate immune system and viral replication is established. To win this race, viruses have established multiple strategies to inhibit the cellular...
3.
Stanifer M, Rippert A, Kazakov A, Willemsen J, Bucher D, Bender S, et al.
Cell Microbiol
. 2016 Jun;
18(12):1831-1845.
PMID: 27279006
Intestinal epithelial cells (IECs) constitute the primary barrier that separates us from the outside environment. These cells, lining the surface of the intestinal tract, represent a major challenge that enteric...
4.
Borrmann S, Straimer J, Mwai L, Abdi A, Rippert A, Okombo J, et al.
Sci Rep
. 2013 Nov;
3:3318.
PMID: 24270944
Early identification of causal genetic variants underlying antimalarial drug resistance could provide robust epidemiological tools for timely public health interventions. Using a novel natural genetics strategy for mapping novel candidate...
5.
Borrmann S, Sasi P, Mwai L, Bashraheil M, Abdallah A, Muriithi S, et al.
PLoS One
. 2011 Nov;
6(11):e26005.
PMID: 22102856
Background: The emergence of artemisinin-resistant P. falciparum malaria in South-East Asia highlights the need for continued global surveillance of the efficacy of artemisinin-based combination therapies. Methods: On the Kenyan coast...
6.
Mwai L, Kiara S, Abdirahman A, Pole L, Rippert A, Diriye A, et al.
Antimicrob Agents Chemother
. 2009 Sep;
53(12):5069-73.
PMID: 19770282
We have analyzed the in vitro chemosensitivity profiles of 115 Kenyan isolates for chloroquine (CQ), piperaquine, lumefantrine (LM), and dihydroartemisinin in association with polymorphisms in pfcrt at codon 76 and...
7.
Sasi P, Abdulrahaman A, Mwai L, Muriithi S, Straimer J, Schieck E, et al.
J Infect Dis
. 2009 May;
199(11):1575-82.
PMID: 19405863
In light of reports of increasing resistance of parasites to amodiaquine in African countries in which Plasmodium falciparum is endemic as well as the paucity of recent in vitro sensitivity...
8.
Kralev S, Zimmerer E, Brueckmann M, Lang S, Kalsch T, Rippert A, et al.
Clin Chem Lab Med
. 2009 Mar;
47(4):446-51.
PMID: 19278364
Background: An important role in the acceleration of vascular disease has been previously suggested for advanced glycation end products. N(epsilon)-(carboxymethyl)lysine (CML) is an advanced glycation end product formed on protein...
9.
Hodel E, Marfurt J, Muller D, Rippert A, Borrmann S, Muller I, et al.
Trans R Soc Trop Med Hyg
. 2008 Jul;
102(11):1151-3.
PMID: 18599099
We describe here the results of an analysis of Plasmodium falciparum multidrug resistance protein 1 (pfmdr1) gene copy number from 440 field isolates from Papua New Guinea. No multiple copies...